|[March 13, 2014]
Covidien Launches Symbotex™ Composite Mesh for Surgical Laparoscopic and Open Ventral Hernia Repair
DUBLIN, Ireland --(Business Wire)--
Further strengthening its broad line of hernia repair products, Covidien
plc (NYSE: COV) today announced the U.S. launch of Symbotex™
composite mesh, an innovative product designed to make it easier for
surgeons to perform surgical laparoscopic and open ventral hernia
Symbotex™ composite mesh for surgical laparoscopic and open ventral hernia repair is designed to offer patients optimal hernia repair performance. (Photo: Business Wire)
A ventral hernia can develop when the outer layers of the abdominal wall
weaken, bulge or tear, with most hernias resulting from strain on the
abdominal muscles. Hernias can grow larger over time and cause serious
complications if not surgically repaired.
"Through ongoing collaboration with our customers we know there is a
eed for a mesh that is easy to use and provides optimal repair for
patients and we believe Symbotex provides the best of both worlds," said
Rob Claypoole, vice president and general manager, Hernia Care,
Covidien. "With the addition of Symbotex, our hernia product line offers
surgeons an even broader choice of unique solutions to address diverse
Symbotex composite mesh is dual sided, comprising a macroporous
monofilament, hydrophilic textile in a three-dimensional construction
that allows for reinforced strength, memory shape and significant tissue
ingrowth. A bioabsorbable collagen film on the visceral side minimizes
Symbotex mesh offers surgeons improved ease of use with an orientation
marker that facilitates correctly placing the mesh over the hernia
defect. Additionally, Symbotex mesh is transparent, offering
improvements to the visualization of the anatomy during mesh placement
and fixation. Symbotex composite mesh is available in a variety of
shapes and sizes for laparoscopic and open ventral hernia repair.
The company announced the U.S. rollout at the American Hernia Society's
16th Annual Hernia Repair meeting, taking place in Las Vegas,
Nevada from March 13 through March 15.
In addition to Symbotex composite mesh, Covidien is showcasing the
latest innovations to its portfolio of hernia repair products, including
AccuMesh™ positioning system and ProGrip™ laparoscopic self-fixating
mesh. For more information, please visit AHS Booth #500/502.
Symbotex composite mesh received 510(k) clearance from the U.S. Food and
Drug Administration in August 2013.
Covidien is a leading global health care products company that creates
innovative medical solutions for better patient outcomes and delivers
value through clinical leadership and excellence. Covidien develops,
manufactures and sells a diverse range of industry-leading medical
device and supply products. With 2013 revenue of $10.2 billion, Covidien
has more than 38,000 employees worldwide in more than 70 countries, and
its products are sold in over 150 countries. Please visit www.covidien.com
to learn more about our business.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20140313005177/en/
[ Back To TMCnet.com's Homepage ]